Belite Bio (BLTE) Cash & Equivalents (2021 - 2025)

Belite Bio's (BLTE) quarterly Cash & Equivalents came in at $15.6 million in Q4 2025, down 50.62% year-on-year from $31.7 million in Q4 2024, and down 90.04% quarter-over-quarter from $157.0 million in Q3 2025.

Belite Bio (BLTE) Cash & Equivalents (2021 - 2025) Analysis & Trends

Belite Bio's Cash & Equivalents history runs 5 years deep, the most recent figure standing at $15.6 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 50.62% year-over-year to $15.6 million in Q4 2025; TTM through Dec 2025 was $15.6 million, a 50.62% decrease from a year earlier, with the FY2025 full-year figure at $15.6 million, down 50.62% from the prior year.
  • Cash & Equivalents eased to $15.6 million in Q4 2025 per BLTE's latest filing, from $157.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $157.0 million in Q3 2025 and bottomed at $15.6 million in Q4 2025.
  • The 5-year median for Cash & Equivalents is $36.9 million (2022), against an average of $58.7 million.
  • Across the five-year window, Cash & Equivalents surged 142.67% in 2022 and slumped 64.07% in 2024, its largest moves.
  • Year by year, Cash & Equivalents stood at $17.3 million in 2021, then surged by 142.67% to $42.1 million in 2022, then jumped by 109.45% to $88.2 million in 2023, then slumped by 64.07% to $31.7 million in 2024, then tumbled by 50.62% to $15.6 million in 2025.
  • Per Business Quant, the three latest BLTE Cash & Equivalents figures stand at $15.6 million (Q4 2025), $157.0 million (Q3 2025), and $31.7 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 82.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 61.40 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.26 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.49 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 3.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 440.94 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 1.71 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 15.64 Mn
Sep 30, 2025 157.03 Mn
Dec 31, 2024 31.68 Mn
Dec 31, 2023 88.16 Mn
Dec 31, 2022 42.09 Mn
Dec 31, 2021 17.34 Mn